Abstract:The aim of this study was to evaluate the breath hydrogen test in the diagnosis of small intestine bacterial overgrowth associated with asymptomatic environmental enteropathy in children living in an urban slum. Fifty school-age children living in a slum and 50 children who attended a private health clinic in the same town were included in the study. Breath hydrogen test was carried out after the administration of lactulose or glucose on two different days. Bacterial overgrowth was diagnosed when the hydrogen … Show more
“…9,11 The gut microbiome of infants in developing countries differs significantly from that of infants in industrialised countries, with higher rates of bacterial overgrowth, increased parasitic load and "tropical enteropathy.' 9,[32][33][34] The interaction of gut microbes with rotavirus vaccine may reduce the titer of vaccine virus available to infect the target cells within the small intestine, where viral replication occurs to induce immune responses. Thus it is possible that the composition of the intestinal microbiota influences vaccine immune responses, and contributes to the decreased vaccine efficacy observed in Africa and Asia.…”
Section: Hypotheses For Reduced Efficacy Of Rotavirus Vaccines In Devmentioning
Rotavirus gastroenteritis is a leading global cause of mortality and morbidity in young children due to diarrhea and dehydration. Over 85% of deaths occur in developing countries. In industrialised countries, 2 live oral rotavirus vaccines licensed in 2006 quickly demonstrated high effectiveness, dramatically reducing severe rotavirus gastroenteritis admissions in many settings by more than 90%. In contrast, the same vaccines reduced severe rotavirus gastroenteritis by only 30-60% in developing countries, but have been proven life-saving. Bridging this "efficacy gap" offers the possibility to save many more lives of children under the age of 5. The reduced efficacy of rotavirus vaccines in developing settings may be related to differences in transmission dynamics, as well as host luminal, mucosal and immune factors. This review will examine strategies currently under study to target the issue of reduced efficacy and effectiveness of oral rotavirus vaccines in developing settings.
“…9,11 The gut microbiome of infants in developing countries differs significantly from that of infants in industrialised countries, with higher rates of bacterial overgrowth, increased parasitic load and "tropical enteropathy.' 9,[32][33][34] The interaction of gut microbes with rotavirus vaccine may reduce the titer of vaccine virus available to infect the target cells within the small intestine, where viral replication occurs to induce immune responses. Thus it is possible that the composition of the intestinal microbiota influences vaccine immune responses, and contributes to the decreased vaccine efficacy observed in Africa and Asia.…”
Section: Hypotheses For Reduced Efficacy Of Rotavirus Vaccines In Devmentioning
Rotavirus gastroenteritis is a leading global cause of mortality and morbidity in young children due to diarrhea and dehydration. Over 85% of deaths occur in developing countries. In industrialised countries, 2 live oral rotavirus vaccines licensed in 2006 quickly demonstrated high effectiveness, dramatically reducing severe rotavirus gastroenteritis admissions in many settings by more than 90%. In contrast, the same vaccines reduced severe rotavirus gastroenteritis by only 30-60% in developing countries, but have been proven life-saving. Bridging this "efficacy gap" offers the possibility to save many more lives of children under the age of 5. The reduced efficacy of rotavirus vaccines in developing settings may be related to differences in transmission dynamics, as well as host luminal, mucosal and immune factors. This review will examine strategies currently under study to target the issue of reduced efficacy and effectiveness of oral rotavirus vaccines in developing settings.
“…No control group was used nor comparison of breath tests to other populations made[5]. Dos Reis and colleagues expanded on these findings in a study where fifty asymptomatic children aged 5 to 11 years old living in an urban slum in Brazil were compared to a matched control group of fifty children who lived in the same city but had the financial resources to seek healthcare at a private clinic[4]. Prevalence of SIBO in the slum dwelling children was 37.5%, whereas only 2.1% of the control group had the condition.…”
Section: Sibo Associated With Unsanitary Living Conditionsmentioning
Small intestine bacterial overgrowth (SIBO) occurs when colonic quantities of commensal bacteria are present in the small bowel. SIBO is associated with conditions of disrupted GI motility leading to stasis of luminal contents. Recent data show that SIBO is also found in children living in unsanitary conditions that do not have access to clean water. SIBO leads to impaired micronutrient absorption and increased GI permeability, both of which may contribute to growth stunting in children. SIBO also disrupts mucosal immunity and has been implicated in oral vaccination underperformance and the development of celiac disease. SIBO in the setting of the impoverished human habitat may be an under recognized cause of pediatric morbidity and mortality in the developing world.
“…Poor sanitation in low-income countries could lead to higher exposure to fecal bacteria and increased incidence of enteric infection. The continuous exposure to fecal bacteria could result in bacterial overgrowth in the small intestine; numerous studies have found such overgrowth in children living with EE symptoms, by utilizing hydrogen breath tests (Fagundes Neto et al, 1994; Khin-Maung-U et al, 1992; dos Reis et al, 2007) or direct sampling of the small intestinal aspirate (Heyworth and Brown, 1975; Omoike and Abiodun, 1989). This overgrowth of microbes may cause the pathological changes characteristic of EE, in particular, villous blunting, increased intestinal permeability, and chronic inflammation that impair the proximal small intestine and subsequently reduce nutrient absorption (Lin et al, 2013; Ngure et al, 2014; Weisz et al, 2012).…”
Section: Ibd As a Platform To Understand Other Intestinal Diseasesmentioning
Summary
The intestinal microbiota, which is composed of bacteria, viruses, and micro-eukaryotes, acts as an accessory organ system with distinct functions along the intestinal tract that are critical for health. This review focuses on how the microbiota drives intestinal disease through alterations in microbial community architecture, disruption of the mucosal barrier, modulation of innate and adaptive immunity, and dysfunction of the enteric nervous system. Inflammatory bowel disease is used as a model system to understand these microbial-driven pathologies, but the knowledge gained in this space is extended to less well studied intestinal diseases that may also have an important microbial component, including environmental enteropathy and chronic colitis-associated colorectal cancer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.